Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Becker

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
American Heart Journal|September 1, 1993
A comparison of heparin strategies after thrombolytic therapyR C Becker, J M Corrao, S P Ball, et al.
Journal of the American College of Cardiology|May 15, 1998
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial InfarctionF A Spencer, R J Goldberg, R C Becker, et al.
Seminars in Surgical Oncology|January 1, 1985
Primary tumors of the heart: a review with emphasis on diagnosis and potential treatment modalitiesR C Becker, J S Loeffler, K A Leopold, et al.
Cardiology|January 1, 1990
Coronary heart disease risk factors in womenJ M Corrao, R C Becker, I S Ockene, et al.
American Heart Journal|October 20, 1998
Pathobiology of thrombin in acute coronary syndromesR C Becker, E G Bovill, M J Seghatchian, et al.
Coronary Artery Disease|April 1, 1994
The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation GroupR C Becker, R P Tracy, E G Bovill, et al.
Digestive Diseases and Sciences|March 1, 1985
Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver diseaseS N Moussavian, R C Becker, J L Piepmeyer, et al.
Hamostaseologie|December 7, 2007
Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapyR C Becker, S Oney, K C D Becker, et al.
American Heart Journal|January 1, 1991
Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part IR C Becker, J M Corrao, R Harrington, et al.
Current Pharmaceutical Biotechnology|February 23, 2012
Antidote control of aptamer therapeutics: the road to a safer class of drug agentsK M Bompiani, R S Woodruff, R C Becker, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
American Heart Journal|September 1, 1993
A comparison of heparin strategies after thrombolytic therapyR C Becker, J M Corrao, S P Ball, et al.
Journal of the American College of Cardiology|May 15, 1998
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial InfarctionF A Spencer, R J Goldberg, R C Becker, et al.
Seminars in Surgical Oncology|January 1, 1985
Primary tumors of the heart: a review with emphasis on diagnosis and potential treatment modalitiesR C Becker, J S Loeffler, K A Leopold, et al.
Cardiology|January 1, 1990
Coronary heart disease risk factors in womenJ M Corrao, R C Becker, I S Ockene, et al.
American Heart Journal|October 20, 1998
Pathobiology of thrombin in acute coronary syndromesR C Becker, E G Bovill, M J Seghatchian, et al.
Coronary Artery Disease|April 1, 1994
The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation GroupR C Becker, R P Tracy, E G Bovill, et al.
Digestive Diseases and Sciences|March 1, 1985
Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver diseaseS N Moussavian, R C Becker, J L Piepmeyer, et al.
Hamostaseologie|December 7, 2007
Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapyR C Becker, S Oney, K C D Becker, et al.
American Heart Journal|January 1, 1991
Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part IR C Becker, J M Corrao, R Harrington, et al.
Current Pharmaceutical Biotechnology|February 23, 2012
Antidote control of aptamer therapeutics: the road to a safer class of drug agentsK M Bompiani, R S Woodruff, R C Becker, et al.
Pageof 15